Journal
JOURNAL OF BACTERIOLOGY
Volume 182, Issue 11, Pages 3183-3190Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JB.182.11.3183-3190.2000
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI042797, T32 AI007323, AI07323, AI42797] Funding Source: Medline
Ask authors/readers for more resources
Pathogenic Yersinia species employ type III machines to target effector Yops into the cytosol of eukaryotic cells. Yersinia tyeA mutants are thought to be defective in the targeting of YopE and YopH without affecting the injection of YopM, YopN, YopO, YopP, and YopT into the cytosol of eukaryotic cells. One model suggests that TyeA may form a tether between YopN (LcrE) and YopD on the bacterial surface, a structure that may translocate YopE and YopH across the plasma membrane of eukaryotic cells (NI. Iriarte, M. P. Sory, A. Poland, A. P. Boyd, S. D. Mills, I. Lambermont, and G. R. Cornelis, EMPO J. 17:1907-1918, 1998). We have examined the injection of Yop proteins by tyeA mutant yersiniae with the digitonin fractionation technique. We find that tyeA mutant yersiniae not only secreted YopE, YopH, YopM, and YopN into the extracellular medium but also targeted these polypeptides into the cytosol of HeLa cells. Protease protection, cell fractionation, and affinity purification experiments suggest that TyeA is located intracellularly and binds to YopN or YopD. We propose a model whereby TyeA functions as a negative regulator of the type III targeting pathway in the cytoplasm of yersiniae, presumably by preventing the export of YopN.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available